1. Clinical diagnosis and surgical management of 110 cases of facial nerve schwannomas
Na SAI ; Weiju HAN ; Mengmeng WANG ; Xuan QIN ; Tong ZHANG ; Weidong SHEN ; Jun LIU ; Pu DAI ; Shiming YANG ; Dongyi HAN
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2019;54(2):101-109
		                        		
		                        			 Objective:
		                        			To elucidate the clinical behavior, causes of misdiagnosis, surgical management, and outcomes of facial nerve schwannomas (FNS).
		                        		
		                        			Methods:
		                        			A retrospective review in Chinese People′s Liberation Army General Hospital from January 1, 2002 to December 31, 2015 was carried out and evaluated 110 patients with FNS, including 50 males and 60 females, aged 16-67 years old. The appropriate surgical strategy was selected based on each patient′s clinical manifestations, facial nerve function, and imaging characteristics. After surgery, patients received follow-up visits to assess their facial nerve functions, with the effect of treatment compared to the reality before surgery. The 
		                        		
		                        	
2.Comparison of curative effect between osteochondral mosaic transplantation and micro-fracture in the treatment of knee joint articular cartilage injury.
Cheng HUANG ; Zhi-Kai LU ; Chen HUANG ; Fei WANG ; Shuai MIAO ; Lei ZENG ; Sai-Jun DAI ; Liang LI ; Chun-Zhi LI
China Journal of Orthopaedics and Traumatology 2019;32(6):539-543
		                        		
		                        			OBJECTIVE:
		                        			To compare the clinical outcomes of microfracture and autogenous osteochondral mosaic transplantation in the treatment of knee joint cartilage injury.
		                        		
		                        			METHODS:
		                        			A retrospective analysis of 71 patients with articular cartilage defects on the femoral condyles who were by autogenous osteochondral mosaic transplantation or microfracture from February 2011 to February 2016, and these patients were followed up for at least 2 years. According to the sugical procedures, the patients were divided into two groups. In the microfracture group, there were 33 patients, 20 males and 13 females, with a mean age of(28.1±4.2) years old; in the mosaicplasty group, there were 38 patients, 26 males and 12 females, with a mean age of(27.8±3.5) years old. The Lysholm knee score, Hospital for Special Surgery (HSS) knee score and the Ahlbäck classification grade were recorded to evaluate the clinical efficacy. Complications were also recorded.
		                        		
		                        			RESULTS:
		                        			The mean Lysholm scores of the microfracture group and the mosaicplasty group improved from 62.9±6.8 and 60.3±7.5 preoperatively to 77.0±5.4 and 85.8±5.6 post-operatively, respectively(<0.05). Mean HSS scores of the microfracture group and the mosaicplasty group improved from 81.5±7.6 and 79.6±8.6 preoperatively to 88.0±4.7 and 91.9±4.7 post-operatively, respectively(<0.05). The mean Lysholm score and HSS score were significantly higher in the mosaicplasty group than those in the microfracture group at the latest follow-up. One patient in the mosaicplasty group suffered superficial wound infection. During the follow-up, no knee osteoarthritis was observed in two groups.
		                        		
		                        			CONCLUSIONS
		                        			Autogenous osteochondral mosaicplasty and microfracture are proved to be safe and effective procedures for knee articular cartilage defects. However, the mosaicplasty has better clinical outcome than the microfracture.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Cartilage, Articular
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Fractures, Stress
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Knee Joint
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Transplantation, Autologous
		                        			;
		                        		
		                        			Treatment Outcome
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
3.GSK923295 as a potential antihepatocellular carcinoma agent causing delay on liver regeneration after partial hepatectomy.
Jia-Cheng TANG ; Ke WU ; Xing ZHENG ; Ming XU ; Yi DAI ; Sai-Sai WEI ; Xiu-Jun CAI
Chinese Medical Journal 2019;132(3):311-318
		                        		
		                        			BACKGROUND:
		                        			The clinical trials emerged centromere protein E inhibitor GSK923295 as a promising anticancer drug, but its function in hepatocellular carcinoma (HCC) remain needs to be fully elucidated, especially as chemotherapy after hepatectomy for liver tumors. We aimed to describe anti-HCC activities of GSK923295 and compare its antiproliferative effects on liver regeneration after partial hepatectomy (PH).
		                        		
		                        			METHODS:
		                        			All subjects were randomized to treatment with either vehicle or GSK923295. Antitumor activity of GSK923295 was assessed by xenograft growth assays. The C57BL/6 mice were subjected to 70% PH and the proliferation was calculated by liver coefficient, further confirmed by immunohistochemistry. The proliferation and cell cycle analysis of liver cell AML12 and HCC cells LM3, HUH7, and HepG2 were investigated using the cell counting kit-8 assay and Flow Cytometry. The chromosome misalignment and segregation in AML12 cells were visualized by immunofluorescence.
		                        		
		                        			RESULTS:
		                        			Treatment with GSK923295 induced antiproliferation in HCC cell lines. It also caused delay on HCC tumor growth instead of regression both in a HCC cell line xenograft model and patient-derived tumor xenograft model. With microarray analysis, CENtromere Protein E was gradually increased in mouse liver after PH. Exposure of liver cells to GSK923295 resulted in delay on a cell cycle in mitosis with a phenotype of misaligned chromosomes and chromosomes clustered. In 70% PH mouse model, GSK923295 treatment also remarkably reduced liver regeneration in later stage, in parallel with the mitotic marker phospho-histone H3 elevation.
		                        		
		                        			CONCLUSION
		                        			The anticancer drug GSK923295 causes a significant delay on HCC tumor growth and liver regeneration after PH in later stage.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Antineoplastic Agents
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Blotting, Western
		                        			;
		                        		
		                        			Bridged Bicyclo Compounds, Heterocyclic
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Carcinoma, Hepatocellular
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Cell Cycle
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Cell Proliferation
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Chromosomal Proteins, Non-Histone
		                        			;
		                        		
		                        			antagonists & inhibitors
		                        			;
		                        		
		                        			Electrophoresis, Polyacrylamide Gel
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Fluorescent Antibody Technique
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunohistochemistry
		                        			;
		                        		
		                        			Liver Neoplasms
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Liver Regeneration
		                        			;
		                        		
		                        			physiology
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Inbred C57BL
		                        			;
		                        		
		                        			Real-Time Polymerase Chain Reaction
		                        			;
		                        		
		                        			Sarcosine
		                        			;
		                        		
		                        			analogs & derivatives
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Xenograft Model Antitumor Assays
		                        			
		                        		
		                        	
4.Phenotype Analysis of 78 Cases of Abnormal Hemoglobin E Homozygotes.
Yun-Hua PAN ; Wei-Xia GUO ; Sai-Li LUO ; Xian-Rong TAN ; Shi-Jun GE ; Bi-Qing YANG ; Zhao-Qing YANG
Journal of Experimental Hematology 2019;27(5):1580-1584
		                        		
		                        			OBJECTIVE:
		                        			To analyze the hematological characteristics of HbE homozygotes.
		                        		
		                        			METHODS:
		                        			Complete blood cells count and hemoglobin electrophoresis were used for phenotypic analysis of 78 cases with HbE homozygotes from Yunnan province, China. The PCR-fluorescence hybridization was used to detect the common gene mutation of thalassemia. The hematological indexes, including MCV, MCH, Hb, HbA2, HbF and HbE were statistically analyzed between groups with different sex, ages and compound α thalassemia status.
		                        		
		                        			RESULTS:
		                        			In HbE homozygotes (HbEE), 89.5% (17/19) children presented mild to moderate microcytic hypochromic anemia, and 10.5% of them presented moderate anemia. 39.6% (19/48) of women with HbEE developed mild anemia ,while 11 cases of male with HbE homozygotes were asymptomatic. The levels of MCV and MCH in HbE homozygotes increased by co-inheritance of α thalassemia mutation.
		                        		
		                        			CONCLUSION
		                        			The clinical phenotype of HbE homozygote shows highly heterogeneous, which is relates with age, sex and co-inheriting α-globin genotypes. In Hb EE women and children are more likely to develop mild to moderate anemia. The microcytic hypochromic anemia degree is relieved when HbEE combined with α- thalassemia.
		                        		
		                        		
		                        		
		                        			Child
		                        			;
		                        		
		                        			China
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Hemoglobin E
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Homozygote
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Phenotype
		                        			;
		                        		
		                        			alpha-Thalassemia
		                        			
		                        		
		                        	
5.Epidemiological survey on clonorchiasis and awareness of prevention and control knowledge in Xinfeng County of Jiangxi Province
Zhe CHEN ; Ting-jun ZHU ; Bin YE ; Chang-hai ZHOU ; Jian-zhong LIU ; Dong LI ; Ying-dan CHEN ; Kun-jiao DAI ; Sai-na LIU ; Wei-sheng JIANG ; Xiao-jun ZENG
Chinese Journal of Schistosomiasis Control 2018;30(5):508-512
		                        		
		                        			
		                        			 Objective To understand the epidemic status of clonorchiasis and awareness of prevention and control knowledge in Xinfeng County of Jiangxi Province, so as to provide the evidences for control measures. Methods The baseline survey was carried out with a clue in vestigation of raw-fish eating behavior in potential endemic areas in 2016.The residents were examined by stool tests. The metacercariae of Clonorchis sinensis in fish, the rediae and cercariae in freshwater mollusk were detected. The feces samples of cats, dogs and pigs were collected and examined by sedimentation technique. Meanwhile, the epidemic factors, health knowledge and behavior were also surveyed. Results The residents in 26 villages had the habit of eating raw freshwater fish, and 19.51% of the respondents had this habit. The average infection rates of the population, Parafossarulus striatulus, freshwater fishes and reservoir hosts were 21.56%, 0, 8.24% and 2.27%, respectively. The infection rate of the population increased with age. There was a significant positive correlation between the behavior and the infection rate of the population (r = 0.88, P < 0.01). Only 11.46% of the respondents knew that eating raw-fish might cause C. sinensis infection, and 5.28% of them knew that C. sinensis was harmful to health. Conclusions Twenty-six villages in five townships were endemic areas of clonorchiasis in Xinfeng County. The permanent solution of prevention and control of clonorchiasis is to strengthen the health education and change the habit of raw-fish eating gradually. 
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail